Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.

Beatrice BescheThomas BlondelEmilie GuillotCatherine Garelli-PaarMark A Oyama

Published in: Journal of veterinary internal medicine (2020)

Torasemide was noninferior to furosemide as first line PO treatment for new onset CHF caused by DMVD. Torasemide significantly decreased risk of cardiac-related death or premature study withdrawal for cardiac reasons compared to furosemide.

Keyphrases

heart failure
mitral valve
left ventricular
atrial fibrillation
replacement therapy
cardiac resynchronization therapy